Oruka Therapeutics, Inc. · NASDAQ:ORKA

Klein Lawrence Otto sold 25,000 Oruka Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Klein Lawrence Otto (Director, Chief Executive Officer) sold 25,000 Oruka Therapeutics, Inc. shares at an average US$83.62 for US$2.09M under a trading plan, leaving 923,128 shares. Filed Oct 2, 2026 (Form 4).

Sold: 25,000 shares
Price: US$83.62 average (US$83.40 to US$84.78)
Value: US$2.09M
Holding after: 923,128 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 1, 2026	Common Stock	Option exercise	25,000	US$7.80	948,128	Direct
Oct 1, 2026	Common Stock	Sale	16,246	US$83.40	931,882	Direct
Oct 1, 2026	Common Stock	Sale	8,554	US$84.03	923,328	Direct
Oct 1, 2026	Common Stock	Sale	200	US$84.78	923,128	Direct

Source

View original at SEC

Related